Ascentage Pharma Group International (AAPG) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $16.6 million.

  • Ascentage Pharma Group International's Accounts Payables changed N/A to $16.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $16.6 million, marking a year-over-year change of. This contributed to the annual value of $12.6 million for FY2024, which is 2290.34% up from last year.
  • As of Q2 2025, Ascentage Pharma Group International's Accounts Payables stood at $16.6 million.
  • Over the past 5 years, Ascentage Pharma Group International's Accounts Payables peaked at $16.6 million during Q2 2025, and registered a low of $10.1 million during Q4 2023.
  • For the 3-year period, Ascentage Pharma Group International's Accounts Payables averaged around $13.1 million, with its median value being $12.8 million (2024).
  • Examining YoY changes over the last 5 years, Ascentage Pharma Group International's Accounts Payables showed a top increase of 2724.6% in 2024 and a maximum decrease of 2724.6% in 2024.
  • Over the past 3 years, Ascentage Pharma Group International's Accounts Payables (Quarter) stood at $10.1 million in 2023, then grew by 27.25% to $12.8 million in 2024, then grew by 29.4% to $16.6 million in 2025.
  • Its Accounts Payables stands at $16.6 million for Q2 2025, versus $12.8 million for Q4 2024 and $10.1 million for Q4 2023.